From the Journals
Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
Clinical training might explain the delay in diagnosis of nail psoriasis in patients with darker skin types.
For the parent, the pigmentation changes, rather than the inflammation, might be the governing issue and the reason that he or she brought the...
Clinicians need to be aware of the potential risk for a paradoxical reaction in patients receiving a tumor necrosis factor α (TNF-α) inhibitor for...
Patients with rheumatic disease who continued TNF blockers during their pregnancy did not have an increased risk of worse fetal and maternal...
Dermatologists are using a variety of treatments for palmoplantar pustulosis, with no clear first-line choices.
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
Patients failing two or more biologic agents of different mechanistic classes “are really suffering. We need to have better guidelines and...
“It is important to construct a framework for carrying out SDM with patients with psoriasis to enhance clinician-patient communication and improve...
News from the FDA/CDC
The drug has also been granted an interchangeability designation and has been approved for six indications.
Of the 35 trials studied, most involved patients with atopic dermatitis.